CEL-SCI Corp. CVM 深 滬
等待開盤 07-18 09:30:00 美东时间
4.17
+0.320
+8.31%
華盛通- 最 高4.25
- 今 開3.83
- 成交量 75.89万股
- 最 低 3.83
- 昨 收 3.85
- 總市值 2141.30万
- 52周最高 39.30
- 市盈率 靜 --
- 換手率 14.78%
- 52周最低 1.98
- 委 比 0.00%
- 總股本 513.50万
- 歷史最高 1425.00
- 量 比 0.13
- 振 幅 10.91%
- 歷史最低 3.83
- 每 手 1
- 風險率 11.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRF S.A. Postpones Extraordinary General Meeting Again Amid Regulatory Scrutiny
BRF SA ( ($BRFS) ) just unveiled an update. On July 11, 2025, BRF S.A. announce...
07-12 05:27
CEL-SCI announces pricing of $5.7 million offering
CEL-SCI (NYSE:CVM) announced on Friday the pricing of a best-efforts offering of 1,500,000 shares of its common stock. Each share of common stock is being sold at an offering price of $3.82 per share,...
07-12 03:04
CEL-SCI Signs Partnership Agreement With Saudi Arabian Pharma And Healthcare Company On Regulatory And Commercial Activities For Multikine In Kingdom Of Saudia Arabia
Strong interest from Saudi investment funds in CEL-SCI, Multikine, and potential joint venture to address the wider Middle East and North Africa marketPatient access and reimbursement/sale in Saudi Arabia within
07-11 21:18
Ambev S.A. Reports June 2025 Securities Transactions
Ambev SA ( ($ABEV) ) has issued an announcement. In June 2025, Ambev S.A. repor...
07-09 05:27
信达生物（01801.HK）7月7日收盘跌4.23%，主力资金净流出1.73亿港元
证券之星消息，截至2025年7月7日收盘，信达生物(01801.HK)报收于82.55港元，下跌4.23%，成交量2382.37万股，成交额19.94亿港元。
07-07 17:56
CEL-SCI Highlights FDA Approval Of Merck's Keytruda As Precedent For Multikine, Citing 66% Reduction In Risk Of Death In Low/Zero PD-L1 Head And Neck Cancer Patients vs. Keytruda's 30% Recurrence Reduction In PD-L1 Positive Tumors
FDA priority review and approval based on interim results sets a positive precedent, paving the path for future Multikine approvalMultikine reduced the risk of death by 66% compared to standard of care in the target
06-18 21:19
信达生物（01801.HK）6月3日收盘涨3.09%，主力资金净流入3284.67万港元
证券之星消息，截至2025年6月3日收盘，信达生物(01801.HK)报收于65.05港元，上涨3.09%，成交量2312.65万股，成交额14.97亿港元。
06-03 18:16
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Urban Outfitters, Inc. (NASDAQ:URBN) rose sharply in today's pre-mark...
05-22 17:30
CEL-SCI plummets 44%, prices $5M stock offering
Clinical stage cancer immunotherapy company CEL-SCI (NYSE:CVM) priced an underwritten public offering of 2M shares at a public offering price of $2.50 per share. Total gross proceeds are expected to...
05-22 17:28
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Longevity Health Holdings (NASDAQ:XAGE) shares moved upwards by 55.5% ...
05-22 05:06
